Patent Assignment
Reel/Frame 048540/0737
Corrective Assignment to Correct the Receiving Party's Name Previously Recorded at Reel: 044165 Frame: 0783. Assignor(S) Hereby Confirms the Grant of Security Interest .
Recorded: 2019-03-08
Pages: 9
Assignor
RECRO GAINESVILLE LLC
Executed: 2017-11-17
Assignee
ATHYRIUM OPPORTUNITIES III ACQUISITION LP
530 FIFTH AVENUE, FLOOR 25, C/O ATHYRIUM CAPITAL MANAGEMENT LP, NEW YORK, NEW YORK, 10036
Covered Properties
(24)
Multiparticulate modified release composition
Patent:
6,228,398 →
Application:
09/566,636 →
Small-Scale Mill and Method Thereof
Patent:
6,431,478 →
Application:
09/583,893 →
Apparatus for Sanitary Wet Milling
Multiparticulate Modified Release Composition
Small-Scale Mill and Method Thereof
System and Method for Milling Materials
Compositions Having a Combination of Immediate Release and Controlled Release Characteristics
Multiparticulate Modified Release Composition
Multiparticulate Modified Release Composition
System and Method for Milling Materials
Multiparticulate modified release composition
Application:
10/827,689 →
Publication:
US 2004/0197405
Method of Using a Small Scale Mill
Multiparticulate modified release composition
Application:
11/372,857 →
Publication:
US 2006/0240105
System and Method for Milling Materials
Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride
Abuse Resistant Pharmaceutical Compositions
Patent:
9,132,096 →
Application:
14/484,761 →
Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride
Abuse Resistant Pharmaceutical Compositions
Abuse Resistant Pharmaceutical Compositions
Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride
Abuse Resistant Pharmaceutical Compositions
Multiparticulate Modified Release Composition
Application:
15/193,514 →
Publication:
US 2017/0000783
Controlled Release Compositions Comprising A Combination Of Isosorbide Dinitrate And Hydralazine Hydrochloride
Abuse Resistant Pharmaceutical Compositions
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement (First Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Patent Security Agreement (Second Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Asset Transfer Agreement
Jul 27, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 028653/0835 →
Assignment of Assignor's Interest
Jul 27, 2012
From: REKHI, GURVINDER SINGH
To: ELAN CORPORATION, PLC
Reel/Frame 028657/0726 →
Change of Name
Jul 27, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028656/0245 →
Notice of Change in Registered Office Address
Jul 27, 2012
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028653/0997 →
Notice of Change in Registered Office Address
Sep 5, 2012
From: EDT PHARMA HOLDINGS
To: EDT PHARMA HOLDINGS
Reel/Frame 028914/0036 →
Asset Transfer Agreement
Sep 5, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 028914/0018 →
Change of Name
Sep 5, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028914/0039 →
Notice of Change in Registered Office Address
Sep 5, 2012
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028914/0106 →
Change of Name
Oct 2, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029064/0645 →
Asset Transfer Agreement
Oct 2, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029066/0655 →
Assignment of Assignor's Interest
Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029103/0465 →
Change of Name
Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029103/0695 →
Release by Secured Party (Second Lien)
Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Intellectual Property Transfer and License Agreement
Aug 1, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033460/0156 →
Property Transfer Agreement
Aug 6, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033483/0891 →
Second Amendment to Intellectual Property Transfer and License Agreement
Aug 8, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033500/0707 →
Assignment of Assignor's Interest
Feb 10, 2015
From: SIDWELL, RICHARD
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 034930/0668 →
Assignment of Assignor's Interest
Feb 10, 2015
From: REKHI, GURVINDER SINGH
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 034930/0229 →
Change of Name
Mar 26, 2015
From: ALKERMES SCIENCE ONE LIMITED
To: DARAVITA LIMITED
Reel/Frame 035264/0078 →
Change of Name
Mar 27, 2015
From: ALKERMES SCIENCE ONE LIMITED
To: DARAVITA LIMITED
Reel/Frame 035279/0701 →
Business Transfer Agreement
Apr 10, 2015
From: DARAVITA LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 035409/0831 →
Business Transfer Agreement
Apr 10, 2015
From: DARAVITA LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 035409/0872 →
Asset Transfer and License Agreement
Apr 10, 2015
From: ALKERMES PHARMA IRELAND LIMITED
To: DV TECHNOLOGY LLC
Reel/Frame 035409/0897 →